| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.67 | 0.01 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |